Kidney Allograft Survival After Acute Rejection, the Value of Follow-Up Biopsies
Author:
Affiliation:
1. Division of Nephrology and Hypertension; Mayo Clinic; Rochester; MN
2. Department of Pathology; Mayo Clinic; Rochester; MN
3. Visiting Clinician, Division Nephrology and Hypertension, Department of Internal Medicine; Mayo Clinic; Rochester; MN
Publisher
Wiley
Subject
Pharmacology (medical),Transplantation,Immunology and Allergy
Reference37 articles.
1. Mycophenolate mofetil for the prevention of acute rejection in primary cadaveric renal allograft recipients;Sollinger;Transplantation,1995
2. A blinded, randomized clinical trial of Mycophenolate Mofetil for the prevention of acute rejection in cadaveric renal transplantation;The Tricontinental Mycophenolate Mofetil Renal Transplantation Study G;Transplantation,1996
3. Predictors of long-term primary cadaveric renal transplant survival;Tesi;Clin Transplant,1993
4. Risk factors for chronic rejection in renal allograft recipients;Almond;Transplantation,1993
5. Lack of improvement in renal allograft survival despite a marked decrease in acute rejection rates over the most recent era;Meier-Kriesche;Am J Transplant,2004
Cited by 151 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Prediction of very early subclinical rejection with machine learning in kidney transplantation;Scientific Reports;2023-12-16
2. Follow‐up biopsies identify high rates of persistent rejection in pediatric kidney transplant recipients after treatment of T cell‐mediated rejection;Pediatric Transplantation;2023-09-26
3. The Protective Role of Protocol Biopsy for Allograft Kidney Maintenance in Kidney Transplantation;Transplantation Proceedings;2023-05
4. Effects of Treating Subclinical Rejection 2 Weeks After Kidney Transplantation, as Determined by Analyzing 1-Year Histologic Outcomes;Transplantation Proceedings;2023-05
5. A Randomized Trial of Valganciclovir Prophylaxis Versus Preemptive Therapy in Kidney Transplant Recipients;Journal of the American Society of Nephrology;2023-02-02
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3